Successful treatment of C1q nephropathy with CD19 targeted Rituximab therapy
Nephrology (Carlton)
.
2017 Mar;22(3):265.
doi: 10.1111/nep.12757.
Authors
Raja Ramachandran
1
,
Joyita Bharati
1
,
Vivekanand Jha
2
Affiliations
1
Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, New Delhi, India.
2
George Institute for Global Health India, New Delhi, India.
PMID:
28205352
DOI:
10.1111/nep.12757
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Adolescent
Female
Glomerulonephritis / drug therapy*
Humans
Immunologic Factors / therapeutic use*
Rituximab / therapeutic use*
Substances
Immunologic Factors
Rituximab